Related Experiment Video
Updated: May 27, 2026
09:54
Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area
Published on: August 10, 2012
Opioid-sensitive GABA inputs from rostromedial tegmental nucleus synapse onto midbrain dopamine neurons
1Vollum Institute, Oregon Health & Science University, Portland, Oregon 97239, USA.
Summary
Opioid drugs affect dopamine release by inhibiting GABA-A IPSCs onto dopamine cells. The rostromedial tegmental nucleus (RMTg) is key in μ-opioid receptor-dependent regulation of dopamine neurons.
Area of Science:
- Neuroscience
- Neuropharmacology
- Cellular Electrophysiology
Background:
- Opioids elevate dopamine release by inhibiting GABA-A inhibitory postsynaptic currents (IPSCs) in dopamine neurons.
- GABA neurons in the rostromedial tegmental nucleus (RMTg) project to midbrain dopamine neurons and express μ-opioid receptors.
- Functional evidence linking RMTg neurons to opioid-dependent dopamine neuron activity modulation was previously limited.
Purpose of the Study:
- To investigate the functional role of RMTg neurons in the opioid-mediated regulation of dopamine neuron activity.
- To determine if μ-opioid receptor activation in RMTg neurons affects their firing and inhibitory output to dopamine neurons.
Main Methods:
- Retrograde tracers were used to identify RMTg neurons projecting to the ventral tegmental area and substantia nigra (VTA/SN).
- Whole-cell current-clamp and cell-attached recordings were performed on identified RMTg neurons in rat brain slices.
- Electrophysiological recordings in dopamine neurons assessed the impact of RMTg stimulation and opioid receptor agonists.
Main Results:
- μ-opioid receptor agonist DAMGO decreased the firing rate and hyperpolarized RMTg neurons; κ- and δ-opioid agonists had no effect.
- Recordings from dopamine neurons showed spontaneous IPSCs sensitive to μ-opioid receptor activation.
- Stimulation of RMTg neurons evoked GABA-A IPSCs in dopamine neurons, which were inhibited by DAMGO.
Conclusions:
- The RMTg provides a dense, μ-opioid receptor-sensitive GABAergic innervation to VTA/SN dopamine neurons.
- The RMTg plays a critical role in the μ-opioid receptor-dependent regulation of midbrain dopamine neuron activity.
- This study elucidates a key neural circuit underlying opioid effects on the dopamine system.
More Related Videos
Related Concept Videos
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:15Drug Abuse and Addiction: Pharmacological Phenomena
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:26Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...